OKYO Pharma’s U.S. Initial Public Offering

In UK Orrick Herrington & Sutcliffe LLP, advised on the matter.Orrick Herrington & Sutcliffe LLP advised OKYO Pharma with a team including Edward Dyson (Equity Capital…

This content is for members only.
Join Now
Already a member? Log in here

Author: Giulia Di Palma

This content is for members only.
Join Now
Already a member? Log in here